Suzanne K. Swan - Concepedia

Author

Suzanne K. Swan

Also Known As

A.L. Pittenger, Rosamond Hong, S K Swan, S SWAN, S Swan, S. Swan, S.K. Swan, SUZANNE K. SWAN, Sam Swan, Shobha Swaminathan

118

Publications

5.7K

Citations

H-Index

124

Concepts

All Affiliations

Hennepin County Medical Center DaVita Clinical Research (United States)Orlando Clinical Research Center Center for Clinical Research (United States)Oregon Health & Science University

About

Suzanne K. Swan is an author at Hennepin County Medical Center specializing in nephrology, medicine, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	42	2.6K
2	Health Sciences	5	5	446
3	Social Sciences	4	4	235
4	Arts	2	2	133
5	Behavioral Sciences	2	2	109

Suzanne K. Swan

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Circulating Factor Associated with Increased Glomerular Permeability to Albumin in Recurrent Focal Segmental Glomerulosclerosis Virginia J. Savin, Ram Sharma, Mukut Sharma, New England Journal of Medicine	1996	710
The Pharmacokinetics and Pharmacodynamics of Argatroban: Effects of Age, Gender, and Hepatic or Renal Dysfunction Suzanne K. Swan, Marcie J. Hursting Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2000	371
Effect of Cyclooxygenase-2 Inhibition on Renal Function in Elderly Persons Receiving a Low-Salt Diet Suzanne K. Swan, David W. Rudy, Kenneth C. Lasseter, Annals of Internal Medicine	2000	336
Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients Allen R. Nissenson, Suzanne K. Swan, Jill S. Lindberg, American Journal of Kidney Diseases HemodialysisDarbepoetin AlfaRenal FunctionHemodialysis PatientsMedicine	2002	213
Effect of Renal Insufficiency on the Pharmacokinetics of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor Arthur Bergman, Josée Côté, Bingming Yi, Diabetes Care Healthy SubjectsPharmacotherapyPharmacokineticsRenal FunctionRenal Excretion	2007	194
Pharmacokinetics of Micafungin in Healthy Volunteers, Volunteers With Moderate Liver Disease, and Volunteers With Renal Dysfunction Mary F. Hébert, Helen Smith, Thomas Marbury, The Journal of Clinical Pharmacology PharmacotherapyPhysiologically-based Pharmacokinetic ModelingPharmacokineticsSecondary MetabolismRenal Function	2005	178
The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects Vandana Mathur, Suzanne K. Swan, Lawrence J. Lambrecht, Critical Care Medicine	1999	176
A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease Patrick Murray, Bharathi Reddy, Eric Grossman, Kidney International HemodialysisUrologyRenal FunctionArgatroban Treatment RegimensMedicine	2004	140
Posaconazole Pharmacokinetics, Safety, and Tolerability in Subjects With Varying Degrees of Chronic Renal Disease Ronan Courtney, A Sansone, Winter J. Smith, The Journal of Clinical Pharmacology Healthy SubjectsDialysis TherapyClinical MycologyPharmacotherapyAntimicrobial Chemotherapy	2005	126
Prevalence of family violence in clients entering substance abuse treatment Caroline J. Easton, Suzanne K. Swan, Rajita Sinha Journal of Substance Abuse Treatment Family MedicineSubstance AbusePartner ViolenceSubstance UsePsychiatry	2000	118

Page 1